Angiogenesis inhibitors targeting the VEGF pathway may also elicit tumor adaptation and progression to stages of greater malignancy, with heightened invasiveness and in some cases increased lymphatic and distant metastasis (145). This evidence concerns the gene VEGFA and neoplasm.